Express Pharma

Glenmark inks agreement with AstraZeneca to commercialise Pulmicort Respules in Colombia

As per this agreement, AstraZeneca remains the holder of the registration for Pulmicort Respules, and will manufacture the drug. Glenmark will commercialise the product in Colombia

0 325